Literature DB >> 2248182

Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone.

N D Mostow1, T R Vrobel, D Noon, L Rakita.   

Abstract

To shorten the delay in the onset of antiarrhythmic effect when using amiodarone for the conversion of refractory atrial tachyarrhythmias to sinus rhythm, 19 patients were given oral amiodarone according to a high-dose loading protocol. In 18 of 19 patients (95%), sinus rhythm was restored 36 hours (range, 0 to 96 hours) after starting amiodarone. The conversion occurred as a result of amiodarone therapy alone within 48 hours in 12 patients (63%), and by amiodarone therapy plus electrical cardioversion at 48 to 96 hours in six patients (32%). Minor side effects were noted in eight patients (42%). No major side effects were encountered. The length of hospital stay after initiating amiodarone therapy was 3.6 days (range, 2 to 5 days). High-dose oral amiodarone loading is a safe and effective method for the rapid conversion of atrial tachyarrhythmias to sinus rhythm.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2248182     DOI: 10.1016/0002-8703(90)90248-v

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

Review 1.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

Review 2.  The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide.

Authors:  O A Obel; A J Camm
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 3.923

Review 3.  Prevention of and medical therapy for atrial arrhythmias in heart failure.

Authors:  A U Khand; J G F Cleland; P C Deedwania
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

4.  Tolerance of High-Dose Oral Amiodarone for Cardioversion of Atrial Flutter.

Authors:  Vincent K Le; Katherine M Kavanagh; Satish R Raj; P Timothy Pollak
Journal:  CJC Open       Date:  2022-04-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.